Aspivix

Switzerland - Renens, VD

• 17/11/2022
• Series A
• $5,000,000

We’re a medical device company in Women’s Health based in Switzerland developing next-generation devices for gynecology.

Our flagship product - Carevix™ - is the world’s first suction cervical stabilizer clinically proven to reduce pain and bleeding associated with transcervical procedures commonly performed in gynecology e.g., IUD insertion.

More than 90 million women worldwide are impacted by the tenaculum, an instrument invented over a century ago and considered the standard of care.

Carevix is currently under development. Commercial release in expected for 2H2022 in the USA and selected European markets.

At Aspivix, we are driven by our vision to make Gynecology. Now modern.

Related People

Mathieu HorrasCo Founder

Switzerland - Basel, Basel

“The best way to predict the future is to create it.” - P. Drucker

This is at the very heart of my motivation as an entrepreneur, truly passionate about medical device industry and always eager to connect with others.

I’m interested in hearing from former colleagues, managers, or just interesting creative folks, so feel free to contact me if you’d like to connect. I can be reached either through this profile orphone at +41 79 103 22 06.

LinkedIn https://www.linkedin.com/in/mathieu-horras/?locale=en_US